Wednesday, July 8, 2026

Patent intelligence · US

US 9011888

Organic-inorganic composite particles, process for producing the same, dispersion containing the particles, and cosmetic containing the part…

granted A61KA61K2800/412A61K2800/614A61K8/0241
Status granted
Linked drugs 2
Pipeline programs 6
Years to expiry 9
Applicant portfolio 61
Patent details — US 9011888
Jurisdiction
US
Status
granted
Grant date
Apr 21, 2015
Expiration
Apr 16, 2035
Claims
8
CPC classes
A61K, A61K2800/412, A61K2800/614, A61K8/0241
View on Google Patents ↗

Quick answer

US 9011888 (Organic-inorganic composite particles, process for producing the same, dispersion containing the particles, and cosmetic containing the particles) is held by JGC Catalysts and Chemicals Ltd.. Status: granted. Granted Apr 21, 2015. Expires Apr 16, 2035 (9 years remaining) — relevant for patent-cliff and LOE planning.

Key facts

Grant date
Expiration
Claims
8
CPC classes
A61K, A61K2800/412, A61K2800/614, A61K8/0241, A61K8/735

More from JGC Catalysts and Chemicals Ltd.

Related pharmaceutical patents in our USPTO index.

  1. US 11806421

    Porous-cellulose particles and production method thereof, and cosmetic

    JGC Catalysts and Chemicals Ltd. · Expires Nov 2, 2043

    granted
  2. US 11701307

    Organic-inorganic composite particles, manufacturing method therefor, and cosmetic

    JGC Catalysts and Chemicals Ltd. · Expires Jul 13, 2043

    granted
  3. US 11491212

    Subcutaneous administration of modified factor IX polypeptides and treatment of hemophilia B

    Catalyst Biosciences, Inc. · Expires Nov 3, 2042

    granted
  4. US 11401513

    Modified membrane type serine protease 1 (MTSP-1) polypeptides and methods of use

    Catalyst Biosciences, Inc. · Expires Jul 28, 2042

    granted
  5. US 11384062

    Deuterated (S)-2-(4-(piperidin-3-yl)phenyl)-2H-indazole-7-carboxamide

    CombiPhos Catalysts, Inc. · Expires Jul 7, 2042

    granted
  6. US 11266724

    Modified factor VII polypeptides for subcutaneous administration and on-demand treatment

    Catalyst Biosciences, Inc. · Expires Mar 3, 2042

    granted
  7. US 11203749

    Factor VII polypeptides that are modified and uses thereof

    Catalyst Biosciences, Inc. · Expires Dec 16, 2041

    granted
  8. US 11020326

    Hollow particles and cosmetic

    JGC Catalysts and Chemicals Ltd. · Expires May 27, 2041

    granted

Frequently asked questions

What is US patent 9011888?

US 9011888 (Organic-inorganic composite particles, process for producing the same, dispersion containing the particles, and cosmetic containing the particles) is held by JGC Catalysts and Chemicals Ltd.. Status: granted. Granted Apr 21, 2015. Expires Apr 16, 2035 (9 years remaining) — relevant for patent-cliff and LOE planning.

Who owns US 9011888?

JGC Catalysts and Chemicals Ltd. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 61 pharmaceutical patents for this assignee.

When does US 9011888 expire?

Our index shows an expiration date of Apr 16, 2035 (9 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.